摩根大通增持国药控股约34.72万股 每股均价约21.41港元

Core Viewpoint - Morgan Stanley increased its stake in China National Pharmaceutical Group (01099) by acquiring 347,233 shares at an average price of HKD 21.4135 per share, totaling approximately HKD 7.4355 million, resulting in a new holding of about 67.1203 million shares, representing a 5% ownership stake [1] Group 1 - Morgan Stanley's acquisition of shares indicates confidence in China National Pharmaceutical Group's future performance [1] - The average purchase price of HKD 21.4135 per share reflects the current market valuation of the company [1] - The total investment of approximately HKD 7.4355 million signifies a strategic move to increase ownership in the company [1]